Mako Surgical (NSDQ:MAKO) filed a pair of lawsuits against Stanmore Implants alleging patent infringement over robotic surgery technology, and filed a complaint with the U.S. International Trade Commission over the alleged violations.
MAKO Surgical Corp.
Robotic surgery: Mass. advisory sends Intuitive Surgical, Mako, Hansen shares down
Shares of the leading robotic surgery device makers all fell today, after a Massachusetts medical board issued an advisory to surgeons warning of possible risks with the cutting-edge technology.
When it comes to robots, opinions run hot
ResMed CEO Farrell hands corner office to his son | Personnel Moves
Mako gets a Wall Street boost as sales soar, losses narrow in 2012
Surgical devices maker Mako Surgical (NSDQ:MAKO), maker of the Rio robotic surgery system, posted impressive boosts to its sales during the 4th quarter and full year of 2012.
BlackRock boosts medical device stakes
BlackRock Inc., 1 of the world’s largest hedge funds, boosted its stake in a clutch of medical device companies, with 1 exception.
Edwards CEO Mussallem details U.S. Sapien sales guidance, updates on CoreValve case | Wall Street Beat
Edwards Lifesciences (NYSE:EW) chairman & CEO Michael Mussallem said the medical device company expects to post U.S. sales of $390 million-$440 million for its flagship Sapien heart valve, adding 200 new sites over the next 2 years to its existing roster of 200 sites.
U.S. robot surgery market gets a new player with FDA nod for Blue Belt Technologies
The U.S. robot-assisted surgery space added a new player this week with FDA clearance for Blue Belt Technologies’ NavioPFS orthopedic surgery system.
The Pittsburgh, Pa.-based device maker won clearance with indication for partial knee replacement, a procedure generally performed using manual instruments, the company noted.
Mako Surgical closes $43 million public offering
Fort Lauderdale-based medical device maker Mako Surgical (NSDQ:MAKO) closed the books on a $40 million funding round with an extra $3 million in net proceeds, the company announced.
Mako said last week that the offering, priced at $13.15 per share for more than 3 million shares, would go toward "commercialization infrastructure" and to cover other corporate expenses.
Mako Surgical prices $40M offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) priced a stock offering of more than 3 million shares at $13.15 apiece, raising some $40 million in total.
Mako Surgical preps $40M public offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) said it’s planning to sell some 3 million shares of its own stock in an offering worth about $40 million.*